PL328135A1 - Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers - Google Patents

Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers

Info

Publication number
PL328135A1
PL328135A1 PL97328135A PL32813597A PL328135A1 PL 328135 A1 PL328135 A1 PL 328135A1 PL 97328135 A PL97328135 A PL 97328135A PL 32813597 A PL32813597 A PL 32813597A PL 328135 A1 PL328135 A1 PL 328135A1
Authority
PL
Poland
Prior art keywords
centchromane
enantiomer
preventing
production
application
Prior art date
Application number
PL97328135A
Other languages
English (en)
Inventor
Michael Shalmi
Ved Prakash Kamboj
Omkar Prasad Asthana
Suprabhat Ray
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PL328135A1 publication Critical patent/PL328135A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL97328135A 1996-01-11 1997-01-09 Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers PL328135A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1000096P 1996-01-11 1996-01-11
DK77696 1996-07-11
PCT/DK1997/000007 WO1997025034A1 (en) 1996-01-11 1997-01-09 Use of the l-enantiomer of centchroman for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of breast cancer

Publications (1)

Publication Number Publication Date
PL328135A1 true PL328135A1 (en) 1999-01-18

Family

ID=26064631

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97328135A PL328135A1 (en) 1996-01-11 1997-01-09 Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers

Country Status (12)

Country Link
EP (1) EP0873119A1 (ko)
JP (1) JP2001500101A (ko)
KR (1) KR19990077157A (ko)
AU (1) AU1367197A (ko)
BR (1) BR9706966A (ko)
CA (1) CA2241462A1 (ko)
CZ (1) CZ217198A3 (ko)
HU (1) HUP9901633A3 (ko)
IL (1) IL124881A0 (ko)
NO (1) NO983177L (ko)
PL (1) PL328135A1 (ko)
WO (1) WO1997025034A1 (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1028724A1 (en) * 1997-11-10 2000-08-23 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans
AU2004200099B2 (en) * 1998-06-11 2006-11-02 Endorecherche, Inc. Medical Uses of A Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
AU2011253842B2 (en) * 1998-06-11 2014-08-14 Endorecherche Inc. Medical Uses of a Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US8835413B2 (en) 2004-10-20 2014-09-16 Endorecherche, Inc. Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
US8268806B2 (en) 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
BRPI0818637A2 (pt) 2007-10-16 2015-04-07 Repros Therapeutics Inc Métodos de tratamento de sintoma da síndrome metabólica, de glicose em jejum prejudicada, da síndrome metabólica e de redução de níveis de glicose em, jejum em sujeito com hipogonadismo hipogonadotrófico secundário ou idiopático
US20100317635A1 (en) 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
EA026675B1 (ru) 2010-06-16 2017-05-31 Эндорешерш, Инк. Способы лечения или предотвращения эстрогензависимых заболеваний
JP2015508825A (ja) 2012-02-29 2015-03-23 レプロス セラピューティクス インコーポレイティド アンドロゲン欠乏症を治療するための併用療法
US9744177B2 (en) 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
EP3373967B9 (en) 2015-11-10 2023-10-04 Paracrine Therapeutics AB Treatment of er-negative breast cancer with an pdgf-cc inhibitor and an anti estrogen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4447622A (en) * 1981-09-22 1984-05-08 Council Of Scientific And Industrial Research Rafi Marg Preparation of l- and d-isomers of dl-3,4-trans-2,2-disubstituted-3,4-diarylchromans and derivatives thereof

Also Published As

Publication number Publication date
EP0873119A1 (en) 1998-10-28
WO1997025034A1 (en) 1997-07-17
KR19990077157A (ko) 1999-10-25
BR9706966A (pt) 1999-05-04
CA2241462A1 (en) 1997-07-17
CZ217198A3 (cs) 1998-11-11
HUP9901633A3 (en) 2000-02-28
AU1367197A (en) 1997-08-01
IL124881A0 (en) 1999-01-26
HUP9901633A2 (hu) 1999-10-28
JP2001500101A (ja) 2001-01-09
NO983177L (no) 1998-07-10

Similar Documents

Publication Publication Date Title
EP0718099A3 (de) Präge-Rotationsmaschine
PL323128A1 (en) Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
PL323130A1 (en) Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
GB9801231D0 (en) A method of treating cancer
PL328135A1 (en) Application of 1-centchromane enantiomer in production of a pharmaceutic agent for preventing or treating mammary cancers
GB2325421B (en) Process for coating surgical needles
EP1075533A4 (en) SMALL MOLECULE ANTICANCER COMPOUNDS AND METHODS FOR PRODUCING THE SAME
EP0742849A4 (en) SURFACE TREATMENT AGENT FOR ZINC PLATED STEEL
PL327505A1 (en) Production of biscyclopentadienylodiene complexes
TW458159U (en) Continuous unloading machine
IL121329A0 (en) A pharmaceutical composition for the treatment of cancer
HUP9601972A3 (en) Rotary machine
GB9614476D0 (en) Rotary machine
GB9708204D0 (en) Tablet coating machine
CZ71095A3 (en) Track ballastway treating machine
EP1007041A4 (en) COMPOSITION FOR TREATING PAIN
GB2323057B (en) Finishing machine for foil and plate manufacture
GB2322151B (en) Synthetic surface treatment apparatus
HU9601450D0 (en) Process for producing pharmaceutical composition for treating neoplasmic syndromas
GB9402665D0 (en) Tunnelling machine
SG101918A1 (en) Tableting process and tableting machine
HUP9602110A3 (en) Pharmaceutical composition for treating prostatismus benignus and chronic prostatitis, and process for producing said composition
GB9704073D0 (en) Lyocell fabric treatment
HU9400631D0 (en) Process for treating tumors
TW360431U (en) Apparatus for rotation generating pattern